Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

76.67
Delayed Data
As of Dec 09
 -0.55 / -0.71%
Today’s Change
73.31
Today|||52-Week Range
129.18
-39.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues417.9M398.1M431.6M413.8M
 
 
 
 
 
Cost of Goods Sold48.7M34.2M30.3M39.5M
 
 
 
 
 
Depreciation And Amortization15.7M16.4M15.0M14.6M
 
 
 
 
 
 
Operating ExpensesGross Income353.5M347.4M386.4M359.7M
 
 
 
 
 
General Expenses407.5M361.1M382.7M378.4M
 
 
 
 
 
Research And Development310.4M255.9M271.0M272.4M
 
 
 
 
 
Total Operating Expenses471.9M411.7M427.9M432.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.0M-13.6M3.7M-18.7M
 
 
 
 
 
Extraordinary Charge-1.5M-687.0K-343.0K-8.0K
 
 
 
 
 
Interest Expense On Debt20.7M20.7M20.2M20.1M
 
 
 
 
 
Other Expenses-1.7M4.4M-1.2M-167.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-77.8M-30.6M-18.0M-39.0M
 
 
 
 
 
Income Taxes-1.4M-5.5M-18.1M-503.0K
 
 
 
 
 
Minority Interest-938.0K-5.5M-28.4M-696.0K
 
 
 
 
 
Net Income-75.5M-41.6M-64.5M-38.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS243.0M243.8M244.5M244.9M
 
 
 
 
 
Shares To Calculate EPS Diluted243.0M243.8M244.5M244.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.17-$0.26-$0.16
 
 
 
 
 
EPS Diluted-$0.31-$0.17-$0.26-$0.16